|
|
| (11) | Number of the document | C 3287 |
| (68) | Number of the document | 3287 |
| (21) | Application number for Supplementary Protection Certificate | PA 2004 009 |
| (22) | Date of filing the application | 2004-10-18 |
| (41) | Date of publication of the application | 2004-12-27 |
| Date of publication of SPC | 2005-06-27 | |
| (24) | Date of coming into effect of SPC | 2014-05-19 |
| (71) |
AstraZeneca AB,
, 151 85 Södertälje,
SE
|
| (73) |
AstraZeneca AB,
, 151 85 Södertälje,
SE
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (92) | 01/7447/4, 01/7448/4, 2001-05-16 |
| (94) | 2016-05-17 |
| (95) | Esomeprazolum (5-metoksi-2-((S)-((4-metoksi-3,5-dimetil-2-piridinil)metil)sulfinil)-1H-benzimidazolo magnio druskos trihidratas) |
| Payment date | Validity (years) | Amount | |
| 2015-04-27 | 2 | 347.00 EUR |
| SPC expired |